Examination Of Vitiligo Skin Samples Before and After UVB Treatment

Stopped early · Not applicable

Conditions studied: Vitiligo

In brief

The keratinocytes of lesional skin of vitiligo compared to normal and perilesional skin will differentially express genes correlating with melanocyte death. Narrow Band UVB should then hopefully reverse the pattern of gene expression back toward normal.

Key facts

Study ID

NCT00177034

Run by

Mimi Cho, MD

People needed

12

Starts

2004-11-01

Expected to finish

2005-12-01

Last updated by the study team

2012-07-10

Who can join

Age: 18 and older, up to 65. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Patients should have non-treated symmetrically active vitiligo for 3 months.

You may not qualify if…

• Less than 18 years old and older that 65, pregnant women, segmental or nonactive vitiligo, patients treated for vitiligo in past 3 month, patients on topical steroid medications, topical tacrolimus or elidel, patients receiving ultraviolet therapy including narrow band UVB, PUVA or tanning beds.

Where it is running

• University of Minnesota — Minneapolis, Minnesota, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.